Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Balk

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
International Archives of Allergy and Immunology|June 1, 1996
Sustained decrease of serum total IgE in cardiac transplant recipientsA W van Toorenenbergen, A H Balk, A M Vermeulen
Lancet (London, England)|April 4, 1992
Reversal of graft rejection with monoclonal anti-interleukin-2 receptorT van Gelder, A H Balk, B Mochtar, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 25, 1995
[Consensus heart failure. Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing]P A de Graeff, A H Balk, W J Remme
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Double valve repair in a transplanted heartE R Wijburg, A H Balk, L A van Herwerden
Nederlands Tijdschrift Voor Geneeskunde|March 20, 1993
[Nocardiosis: a treacherous generalized infection]R A de Man, C Hilvering, H J Groen, et al.
Transplantation Proceedings|December 29, 1998
Cytotoxic T lymphocytes and cytokines in graft vascular disease after clinical heart transplantationW Weimar, N M van Besouw, C C Baan, et al.
The Journal of Infectious Diseases|June 1, 1991
Primary Epstein-Barr virus infection in an immunosuppressed patient: symptoms, serology, and T cell responseA C Kroes, M L Brouwer, M Van Batenburg, et al.
Journal of the American College of Cardiology|February 1, 1992
Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factorsP P De Jaegere, A A Arnold, A H Balk, et al.
Journal of Computer Assisted Tomography|January 1, 1990
MR imaging in assessment of cardiac transplant rejection in humansJ Doornbos, H Verwey, C E Essed, et al.
Chest|February 1, 1990
Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulinH J Metselaar, A H Balk, B Mochtar, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
International Archives of Allergy and Immunology|June 1, 1996
Sustained decrease of serum total IgE in cardiac transplant recipientsA W van Toorenenbergen, A H Balk, A M Vermeulen
Lancet (London, England)|April 4, 1992
Reversal of graft rejection with monoclonal anti-interleukin-2 receptorT van Gelder, A H Balk, B Mochtar, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 25, 1995
[Consensus heart failure. Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing]P A de Graeff, A H Balk, W J Remme
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Double valve repair in a transplanted heartE R Wijburg, A H Balk, L A van Herwerden
Nederlands Tijdschrift Voor Geneeskunde|March 20, 1993
[Nocardiosis: a treacherous generalized infection]R A de Man, C Hilvering, H J Groen, et al.
Transplantation Proceedings|December 29, 1998
Cytotoxic T lymphocytes and cytokines in graft vascular disease after clinical heart transplantationW Weimar, N M van Besouw, C C Baan, et al.
The Journal of Infectious Diseases|June 1, 1991
Primary Epstein-Barr virus infection in an immunosuppressed patient: symptoms, serology, and T cell responseA C Kroes, M L Brouwer, M Van Batenburg, et al.
Journal of the American College of Cardiology|February 1, 1992
Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factorsP P De Jaegere, A A Arnold, A H Balk, et al.
Journal of Computer Assisted Tomography|January 1, 1990
MR imaging in assessment of cardiac transplant rejection in humansJ Doornbos, H Verwey, C E Essed, et al.
Chest|February 1, 1990
Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulinH J Metselaar, A H Balk, B Mochtar, et al.
Pageof 15